Bernard Zinman
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 0.05%
Papers in
-
- Diabetes Treatment and Management 245
- Diabetes Management and Research 133
- Diabetes, Cardiovascular Risks, and Lipoproteins 43
- Surgery 110
- Pancreatic function and diabetes 90
- Co-authors
- John M. Lachin (40 shared papers)John B. Buse (55 shared papers)Ravi Retnakaran (150 shared papers)Silvio E. Inzucchi (66 shared papers)Christoph Wanner (77 shared papers)Anthony J. Hanley (182 shared papers)Odd Erik Johansen (37 shared papers)David Fitchett (65 shared papers)
- Journals
- Diabetes Care (104 papers)Diabetes Obesity and Metabolism (46 papers)The Journal of Clinical Endocrinology & Metabolism (42 papers)Diabetes (39 papers)Diabetologia (25 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Bernard Zinman
639 papers receiving 61.3k citations
Bernard Zinman's Hit Papers
Peers
Comparison fields: 5 of 186
- Endocrinology, Diabetes and Metabolism 36.6k
- Nephrology 3.0k
- Obstetrics and Gynecology 2.8k
- Cardiology and Cardiovascular Medicine 6.1k
- Surgery 12.0k
Countries citing papers authored by Bernard Zinman
This map shows the geographic impact of Bernard Zinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Zinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Zinman more than expected).
Fields of papers citing papers by Bernard Zinman
This network shows the impact of papers produced by Bernard Zinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Zinman. The network helps show where Bernard Zinman may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Zinman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 656 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Hit paper breakdown → | 2015 | 8368 |
| 2 | Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes Hit paper breakdown → | 2016 | 5126 |
| 3 | Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy Hit paper breakdown → | 2008 | 2970 |
| 4 | Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Hit paper breakdown → | 2016 | 2624 |
| 5 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Hit paper breakdown → | 2006 | 2211 |
| 6 | Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes Hit paper breakdown → | 2017 | 1546 |
| 7 | Impaired Fasting Glucose and Impaired Glucose Tolerance Hit paper breakdown → | 2007 | 1073 |
| 8 | Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy Hit paper breakdown → | 2006 | 919 |
| 9 | Liraglutide and Renal Outcomes in Type 2 Diabetes Hit paper breakdown → | 2017 | 880 |
| 10 | Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk Hit paper breakdown → | 2018 | 774 |
| 11 | Are Metabolically Healthy Overweight and Obesity Benign Conditions? Hit paper breakdown → | 2013 | 715 |
| 12 | Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) Hit paper breakdown → | 2009 | 712 |
| 13 | Diabetic Retinopathy and Diabetic Macular Edema Hit paper breakdown → | 2003 | 657 |
| 14 | Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy Hit paper breakdown → | 2008 | 542 |
| 15 | How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial Hit paper breakdown → | 2017 | 534 |
| 16 | Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes Hit paper breakdown → | 2009 | 517 |
| 17 | 2001 | 434 | |
| 18 | Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis Hit paper breakdown → | 2017 | 432 |
| 19 | Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes Hit paper breakdown → | 2017 | 414 |
| 20 | 2008 | 413 |
About Bernard Zinman
Bernard Zinman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Obstetrics and Gynecology and Cardiology and Cardiovascular Medicine, having authored 656 papers that have together received 63.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (245 papers), Diabetes Management and Research (133 papers), Pancreatic function and diabetes (90 papers), Metabolism, Diabetes, and Cancer (76 papers), Gestational Diabetes Research and Management (62 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (43 papers), Diabetes and associated disorders (30 papers) and Diet and metabolism studies (30 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (36.6k citations), Nephrology (3.0k citations), Obstetrics and Gynecology (2.8k citations), Cardiology and Cardiovascular Medicine (6.1k citations) and Surgery (12.0k citations). Bernard Zinman has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include John M. Lachin, John B. Buse, Ravi Retnakaran, Silvio E. Inzucchi, Christoph Wanner, Anthony J. Hanley, Odd Erik Johansen, David Fitchett, Rury R. Holman and Michaela Mattheus. Their work appears in journals such as Diabetes Care, Diabetes Obesity and Metabolism, The Journal of Clinical Endocrinology & Metabolism, Diabetes and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.